FALCO HOLDINGS Co., Ltd. (4671.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In JPY
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1117
First IPO Date
October 29, 2004
| Name | Title | Pay | Year Born |
| Takafumi Fukui | Executive Vice President & Director | 0 | 1965 |
| Tetsuo Goda | GM of Corporate Planning Office & Director | 0 | 1966 |
| Tadashi Yasuda | President, Executive Officer & Chairman | 0 | 1958 |
| Hisayuki Ohba | Executive Officer, GM of Pharma Business Div. & Director | 0 | 1969 |
| Shuhei Kuroda | Executive Officer & Director | 0 | 1973 |
| Kei Shimada | Executive Officer & Director | 0 | 1973 |
| Yoichi Kawata | Managing Executive Officer, GM of Clinical Business Office & Director | 0 | 1962 |
FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various corporations throughout Japan. Its comprehensive range of clinical testing encompasses specialized areas such as genetics, biochemistry, hematology, pathology, immunology, microbiology, and radioimmunoassay. Beyond direct diagnostics, FALCO HOLDINGS also engages in genomic-based drug discovery and the development of biotechnological pharmaceuticals. The company's offerings extend to medical information technology services, as well as environmental and food sanitation testing. They also provide genetic testing tailored for the food industry, catering to manufacturers, retailers, and restaurants. Additionally, FALCO HOLDINGS operates dispensing pharmacies and drugstores. They are also active in the development and sale of medical information systems, notably including "@home Dr.," an electronic medical record system designed for clinics with a high volume of clinical testing, and "TASCAL for ASP," a robust medical support system.